Results 71 to 80 of about 155 (99)

Effect of Combined Treatment with MLC601 (NeuroAiDTM) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies.

Cerebrovasc Dis, 2018
Suwanwela NC, Chen CLH, Lee CF, Young SH, Tay SS, Umapathi T, Lao AY, Gan HH, Baroque Ii AC, Navarro JC, Chang HM, Advincula JM, Muengtaweepongsa S, Chan BPL, Chua CL, Wijekoon N, de Silva HA, Hiyadan JHB, Wong KSL, Poungvarin N, Eow GB, Venketasubramanian N, CHIMES-E Study Investigators.   +22 more
europepmc   +1 more source

Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study.

Cerebrovasc Dis, 2017
Venketasubramanian N, Lee CF, Young SH, Tay SS, Umapathi T, Lao AY, Gan HH, Baroque Ii AC, Navarro JC, Chang HM, Advincula JM, Muengtaweepongsa S, Chan BP, Chua CL, Wijekoon N, de Silva HA, Hiyadan JH, Suwanwela NC, Wong KS, Poungvarin N, Eow GB, Chen CL, CHIMES-E Study Investigators.   +22 more
europepmc   +1 more source

Adaptogens in Long-Lasting Brain Fatigue: An Insight from Systems Biology and Network Pharmacology. [PDF]

Pharmaceuticals (Basel)
Panossian A, Lemerond T, Efferth T.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Protocol for Safety and Efficacy of MLC901 (NeuroAiD II) in Patients With Moderate Traumatic Brain Injury: A Randomized Double-Blind Placebo-Controlled Trial (ANDROMEDA)

Neurosurgery, 2023
BACKGROUND AND OBJECTIVES: Traumatic brain injury (TBI) remains a leading cause of death and disability, affecting approximately 69 million individuals each year worldwide. A significant portion of TBI research has focused on treatments for neuroprotection and/or neurorecovery, with most failing to transition to successful ...
Annabell E, Chua, Vilma Jane, Yacapin, Guillermo L, Manalo, Lourdes K, Ledesma   +3 more
openaire   +2 more sources

A Double-Blind, Placebo-Controlled, Randomized Phase II Pilot Study to Investigate the Potential Efficacy of the Traditional Chinese Medicine Neuroaid (MLC 601) in Enhancing Recovery after Stroke (TIERS)

Cerebrovascular Diseases, 2009
<i>Background and Objective:</i> Previous clinical studies have shown that Neuroaid (MLC 601) may be beneficial in post-stroke rehabilitation. Our aim was to investigate the efficacy of Neuroaid on motor recovery in ischemic stroke patients using rehabilitation endpoints in accordance with the International Conference on Harmonization/Good ...
Kong, K.H., Wee, S.K., Ng, C.Y., Chua, K., Chan, K.F., Venketasubramanian, N., Chen, C.   +6 more
openaire   +2 more sources

P2‐032: Effects of Neuroaid II (MLC901) on App Processing and TAU Phosphorylation

Alzheimer's & Dementia, 2016
Wei Thye Lee Lee, Christopher Chen, Yun-An Lim   +2 more
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

FP05-MO-06 A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential efficacy of a traditional Chinese medicine NeuroAid™ in enhancing recovery after stroke (TIERS)

Journal of the Neurological Sciences, 2009
K.H. Kong, K.W. Seng, Y.N. Chwee, K. Chua, K.F. Chan, N.V. Venketasubramanian, C.L.H. Chen   +6 more
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly